SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

QuickVue® At-Home OTC COVID-19 rapid antigen tests available without a prescription at CVS Pharmacy locations nationwide and online at CVS.com SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: ...

Quidel Corporation QDEL recently announced that it will make its non-prescription QuickVue At-Home OTC COVID-19 Test available to consumers from the next week. The test will be available at more than ...

Agreement will make QuickVue® At-Home rapid antigen tests available without a prescription at 7,600 Walgreens locations nationwide and online at walgreens.com SAN DIEGO--(BUSINESS WIRE)-- Quidel ...

San Diego’s Quidel Corp. boosted its fourth quarter sales forecast on Thursday after the omicron and delta variants sparked increased demand for its rapid at-home COVID-19 tests. The company, which ...

Quidel Corporation (NASDAQ:QDEL) announces that its non-prescription QuickVue At-Home OTC COVID-19 Test is now available in the U.S. for online delivery. “The ability to quickly order and receive the ...

Non-clinical testing for the SARS-CoV-2 virus has been a major goal for regulators across the globe for months. Emergency use authorization (EUA) was just granted by the FDA is for the Quidel Quickvue ...

Quidel Corporation QDEL has been gaining on the back of its strong diagnostics portfolio. A solid third-quarter 2021 performance, along with solid potential in In-Vitro Diagnostics (“IVD”) products, ...

SAN FRANCISCO (KGO) -- Abbott Labs came out with an at-home COVID test in 2020, but now with the Delta variant surging across the country, it's become a popular item. Abbott's COVID-19 antigen test is ...

Shares of Quidel Corp. dipped 5 percent on Friday after the San Diego maker of COVID-19 diagnostic tests said first-quarter revenue would fall short of expectations Quidel revised its quarterly sales ...

Between 2017 and 2020, Abbott’s revenues grew by about 26%, from around $27.4 billion to $34.6 billion, primarily led by a strong growth in diagnostics business, which saw its revenue nearly double to ...

Quidel's Q4 revenue and earnings dropped sharply from the prior-year period. However, the company's results topped consensus estimates. Quidel's future growth drivers include the U.S. launch of a new ...